Logos Global Management LP Zentalis Pharmaceuticals, Inc. Transaction History
Logos Global Management LP
- $513 Million
- Q1 2025
A detailed history of Logos Global Management LP transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 500,000 shares of ZNTL stock, worth $735,000. This represents 0.81% of its overall portfolio holdings.
Number of Shares
500,000Holding current value
$735,000% of portfolio
0.81%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ZNTL
# of Institutions
140Shares Held
60.7MCall Options Held
7.9KPut Options Held
42.5K-
Matrix Capital Management Company, LP Waltham, MA14MShares$20.5 Million6.94% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$7.08 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.26MShares$4.79 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.07MShares$4.51 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.67MShares$3.93 Million0.01% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $83.8M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...